Characteristic | LMR < 2.475 | LMR ≥ 2.475 | r value | P value |
---|---|---|---|---|
Total | 335 | 337 | Â | Â |
Gender | Â | Â | Â | Â |
Male | 277 | 269 | 0.037 | 0.342 |
Female | 58 | 68 | Â | Â |
Age (years) | Â | Â | Â | Â |
<46 | 157 | 159 | −0.003 | 0.935 |
≥46 | 178 | 178 |  |  |
T stage | Â | Â | Â | Â |
T1-T2 | 136 | 137 | <0.001 | 0.988 |
T3-T4 | 199 | 200 | Â | Â |
N stage | Â | Â | Â | Â |
N0-N1 | 138 | 135 | 0.012 | 0.765 |
N2-N3 | 197 | 202 | Â | Â |
Metastasis at presentation | Â | Â | Â | Â |
Absent | 238 | 137 | 0.306 | <0.001 |
Present | 97 | 200 | Â | Â |
Number of metastatic lesions | Â | Â | Â | Â |
1 | 34 | 71 | −0.150 | <0.001 |
≥2 | 301 | 266 |  |  |
Bone metastasis | Â | Â | Â | Â |
Absent | 139 | 141 | −0.004 | 0.927 |
Present | 196 | 196 | Â | Â |
Liver metastasis | Â | Â | Â | Â |
Absent | 197 | 246 | −0.150 | <0.001 |
Present | 138 | 91 | Â | Â |
Lung metastasis | Â | Â | Â | Â |
Absent | 224 | 238 | −0.041 | 0.294 |
Present | 111 | 99 | Â | Â |
Extraregional lymph node metastasis | Â | Â | Â | Â |
Absent | 233 | 264 | −0.100 | 0.009 |
Present | 102 | 73 | Â | Â |
EBV VCA/IgA | Â | Â | Â | Â |
<1:80 | 36 | 44 | −0.037 | 0.339 |
1:80–1:320 | 197 | 198 |  |  |
≥1:640 | 102 | 95 |  |  |
EBV EA/IgA | Â | Â | Â | Â |
<1:10 | 56 | 72 | −0.055 | 0.151 |
1:10–1:20 | 109 | 107 |  |  |
≥1:40 | 170 | 158 |  |  |